Sequential safety monitoring for alerting and stopping a development program

来源 :上海交通大学 | 被引量 : 0次 | 上传用户:coni
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  In pivotal Phase 3 trials where adverse events have been identified in advance,regulatory requirements often call for development programs to adequately demonstrate an acceptable drug safety profile.
其他文献
Testing for white noise is a classical yet important problem in statistics,especially for diagnostic checks in time series modeling.
This talk discusses the average value-at-risk(AVaR)criterion for finite horizon semi-Markov decision processes(SMDPs)in continuous-time.
In this talk,I will give some kinds of risk model with dependence structure,and some criteria under which we discuss the optimization problems.
Data Science programs,including academic,professional,short course and boot-camps,now abound worldwide.
As the treatments for breast cancer improve,disease free survival time is extensively prolonged and pharmaceutical developer faces a new challenge in clinical trial design and conduct based on long te
会议
We propose a dynamic network model for the evolution of an open animal population that is subject to an environmental catastrophe.
The primary objective of cancer phase Ⅰ studies is to determine the maximum tolerated dose(MTD).
In this talk,we will talk about embedding a non-parametric multiple change-point problem into a parametric framework.
In the early phase development of molecularly targeted agents(MTAs),a commonly encountered situation is that the MTA is expected to be more effective for a certain biomarker subgroup,say marker-positi
In this paper,we consider functional partial linear models proposed by Lian(2011)when the response variables are missing at random.